Golden
OS Fund

OS Fund

A venture capital and private equity firm commercializing discoveries in genomics, synthetic biology, artificial intelligence, precision automation, and new materials development.

OS Fund is a venture capital and private equity firm commercializing discoveries in genomics, synthetic biology, artificial intelligence, precision automation, and new materials development that is headquartered in Park Ridge, Illinois and was founded in 2014 by Bryan Johnson, Jeff Klunzinger, and Jeffrey Klunzinger. Notable investments made by OS Fund include: Catalog, Ginkgo Bioworks, Arzeda, Elysium, Emerald Therapeutics, JUST Foods, Synthetic Genomics, Verge Genomics, and Truvian.



OS Fund was founded by Bryan Johnson in 2014, personally funding the venture capital with $100m.

OS Fund I

OS Fund I made 28 investments, with 27 receiving follow on investment, four valued at over a billion dollars, and two were acquired. OS Fund invested in entrepreneurs using applied intelligence in genomics, synthetic biology, diagnostics, new materials, and data and energy.

OS Fund II

On August 7, 2018 OS Fund announced raising $250 million in capital for their OS Fund II investment fund. At the time of the company's OS Fund II announcement, OS Fund also announced that it has already invested $24.9 million (10% of the capital of OS Fund II) into three technology companies; Arzeda, NuMat Technologies, and UBiome. 

Timeline

Associated investment funds

3 Results
Investment Fund
Investment Fund
Total offering (USD)
Total offering (USD)
Location
Location
Date signed
Date signed

Funded Companies

8 Results
Company
Company
Description
Description
Website
Website
Industry
Industry
Location
Location

Arzeda is a biotechnology and software company designing custom microorganisms for industrial applications through computational enzyme design, protein optimization, and metabolic engineering.

Biotechnology microbial genomics company based in San Francisco

A-Alpha Bio is a startup that has built a platform technology and aims to speed up the development of new drugs.

An industrial biotech company developing a commercial bioprocess for manufacturing bio-based malonic acid.

Verge Genomics is a company focused on the discovery and development of drugs for the treatment of neurodegenerative diseases with the use of machine learning and computational genomics.

NuMat Technologies is a company founded by Benjamin Hernandez.

People

Name
Role
LinkedIn

Bryan Johnson

Co-founder



Jeff Klunzinger

Co-founder



Further reading

Title
Author
Link
Type
Date

OS Fund -- Building A Global Biological Immune System

Bryan Johnson

Web



OS Fund Raising $250M to Support Entrepreneurs Building Deep Tech to Solve Global Problems



Web



Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services

3Scan







Arzeda







Atomwise







Augmenta Bioworks







Catalog













Diassess







Elysium













Emulate







Exvivo













Human Longevity Project







Lygos







Matternet







Miroculus







Nanoly Bioscience







NuMat Technologies







Pivot BIo







Planetary Resources







Plethora







Prospect Bio







Sythego







Sythetic Genomics







Tempo Automation







References